Systematic Review of Outcome Measures in 2331 Patients Enrolled in Randomized Controlled Trials of Lipid amphotericin B Formulations for Fever and Neutropenia.

R. FROTHINGHAM

Author address: 

VA Med. Ctr., Durham, NC

Abstract: 

Background: amphotericin B (ampho B) preparations are often used for fever and neutropenia unresponsive to antibiotics (F&N). Methods: Systematic review of published RCTs using ampho B colloidal dispersion (ABCD), ampho B lipid complex (ABLC), or liposomal ampho B (L Amph) for F&N. Abstracted data: Trial quality, success, mortality, fungal breakthrough, infusion reactions, nephrotoxicity, hypokalemia. An unadjusted p
2003

abstract No: 

M-975

Full conference title: 

43rd Interscience Conference on Antimicrobial Agents
    • ICAAC 43rd